NCT00733668View on ClinicalTrials.gov

Efficacy of SEROQUEL in Selective Serotonin Reuptake Inhibitors (SSRI)-Resistant Major Depressive Disorder

PHASE2CompletedINTERVENTIONAL

Timeline

Start Date

March 31, 2006

Primary Completion Date

November 30, 2007

Study Completion Date

November 30, 2007

Conditions

Major Depressive Disorder

Interventions

DRUG

Quetiapine fumarate (Seroquel)

300 mg, PO, 100 mg morning, 200 mg evening, 4 weeks

Trial Locations (4)

Unknown

Research Site, Bruges

Research Site, Leuven

Research Site, Liège

Research Site, Sint-Truiden

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY